sharesgurusharesguru
  • Stocks
  • Ai Screener
  • Sectors
  • Watchlist
LoginSign Up
sharesguru
  • Home
  • Stocks
  • Ai Screener
  • Sectors
  • Watchlist
  • Profile
  • Contact Us
LoginSign Up
sharesguru

Discover the joy of investing.

All the financial data and tools you need, at one place.

Navigation

  • Home
  • Stocks
  • Sectors

Tools

  • Ai Screener
  • Watchlists

Company

  • Contact

Legal

  • Privacy Policy
  • Terms of Service
Copyright © 2025 Knowtilus Technologies Pvt. Ltd.
SummaryLatest NewsSector ComparisonEarnings ReportRevenue & GrowthPeersIncome StatementBalance SheetCash Flow
NH logo

NH - Narayana Hrudayalaya Limited Share Price

Healthcare Services
Sharesguru Stock Score

NH

57/100

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years

₹1700.20+23.40(+1.40%)
Market Closed as of Apr 7, 2026, 15:30 IST
Pros

Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.

Size: Market Cap wise it is among the top 20% companies of india.

Past Returns: Outperforming stock! In past three years, the stock has provided 30.2% return compared to 9.3% by NIFTY 50.

Balance Sheet: Strong Balance Sheet.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Technicals: Bullish SharesGuru indicator.

Profitability: Recent profitability of 11% is a good sign.

Growth: Awesome revenue growth! Revenue grew 25.5% over last year and 59.7% in last three years on TTM basis.

Cons

No major cons observed.

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Sharesguru Stock Score

NH

57/100

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years

Valuation

Market Cap34.27 kCr
Price/Earnings (Trailing)43.72
Price/Sales (Trailing)4.98
EV/EBITDA23.95
Price/Free Cashflow-431.48
MarketCap/EBT36.72
Enterprise Value35.99 kCr

Fundamentals

Revenue (TTM)6.88 kCr
Rev. Growth (Yr)57%
Earnings (TTM)779.27 Cr
Earnings Growth (Yr)-34.3%

Profitability

Operating Margin14%
EBT Margin14%
Return on Equity19.18%
Return on Assets10.07%
Free Cashflow Yield-0.23%

Growth & Returns

Price Change 1W4.4%
Price Change 1M-4.5%
Price Change 6M-5.8%
Price Change 1Y0.00%
3Y Cumulative Return30.2%
5Y Cumulative Return31.6%
7Y Cumulative Return34%
10Y Cumulative Return19%

Cash Flow & Liquidity

Cash Flow from Investing (TTM)-1.32 kCr
Cash Flow from Operations (TTM)990.08 Cr
Cash Flow from Financing (TTM)531.81 Cr
Cash & Equivalents413.57 Cr
Free Cash Flow (TTM)-83.68 Cr
Free Cash Flow/Share (TTM)-4.09

Balance Sheet

Total Assets7.74 kCr
Total Liabilities3.68 kCr
Shareholder Equity4.06 kCr
Current Assets2.79 kCr
Current Liabilities1.25 kCr
Net PPE3.95 kCr
Inventory110.59 Cr
Goodwill120.38 Cr

Capital Structure & Leverage

Debt Ratio0.28
Debt/Equity0.53
Interest Coverage3.83
Interest/Cashflow Ops7.28

Dividend & Shareholder Returns

Dividend/Share (TTM)4.5
Dividend Yield0.24%
Shares Dilution (1Y)0.00%
Shares Dilution (3Y)0.00%
Pros

Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.

Size: Market Cap wise it is among the top 20% companies of india.

Past Returns: Outperforming stock! In past three years, the stock has provided 30.2% return compared to 9.3% by NIFTY 50.

Balance Sheet: Strong Balance Sheet.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Technicals: Bullish SharesGuru indicator.

Profitability: Recent profitability of 11% is a good sign.

Growth: Awesome revenue growth! Revenue grew 25.5% over last year and 59.7% in last three years on TTM basis.

Cons

No major cons observed.

The Good, Bad and Ugly
Growth
Measures how quickly a company is expanding through metrics like revenue growth, earnings growth, and cash flow growth over time. Strong growth can indicate future potential.
Profitability
Shows how efficiently a company turns business activities into profit, using metrics like profit margins, return on equity (ROE), and return on assets (ROA).
Size
Indicates the company's market presence through metrics like market capitalization, total assets, and revenue. Size can influence stability and market influence.
Dilution Rank
Tracks how much the company's shares have increased or decreased over time. Lower dilution means existing shareholders maintain stronger ownership stakes.
Balance Sheet
Evaluates the company's financial health by analyzing assets, debts, and equity. A strong balance sheet indicates financial stability and flexibility.
Momentum
Measures the strength and speed of price movements, showing whether the stock is gaining or losing market favor over different time periods.
Technicals
Analyzes price patterns, trading volumes, and other market indicators to identify potential trading opportunities and market trends.
Smart Money
Tracks the investment activities of institutional investors, hedge funds, and other large financial players who often have deep research capabilities.
Insider Trading
Monitors buying and selling of company shares by executives, directors, and other insiders who may have unique insights into the company's prospects.

Investor Care

Dividend Yield0.24%
Dividend/Share (TTM)4.5
Shares Dilution (1Y)0.00%
Earnings/Share (TTM)38.35

Financial Health

Current Ratio2.24
Debt/Equity0.53

Technical Indicators

RSI (14d)43.89
RSI (5d)54.74
RSI (21d)35.61
MACD SignalSell
Stochastic Oscillator SignalHold
SharesGuru SignalBuy
RSI SignalHold
RSI5 SignalHold
RSI21 SignalHold
SMA 5 SignalBuy
SMA 10 SignalBuy
SMA 20 SignalSell
SMA 50 SignalSell
SMA 100 SignalSell

Summary of Latest Earnings Report from Narayana Hrudayalaya

Summary of Narayana Hrudayalaya's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.

In the earnings call held on February 17, 2026, management of Narayana Hrudayalaya Limited provided a positive outlook for the company's future, particularly focusing on the continued growth in their India operations. Key highlights from the management's commentary include:

  1. Profit Growth: The Indian business has shown a high profit growth for two consecutive quarters, with margin expansion of approximately 150-200 basis points Year-over-Year (YOY). Management aims to maintain these margins in the upcoming quarters.

  2. Revenue Generation: The company is shifting towards higher value configurations, supported by transformation programs, which have led to improved revenue realizations. Increased volume in robotic cardiac surgeries is contributing positively to revenue.

  3. Insurance Segment Breakeven: Management is optimistic about reducing losses in the insurance and clinic business segments, focusing on building awareness and customer attraction without providing a specific timeline for breakeven.

  4. Cayman and UK Performance: The Cayman hospitals recorded revenues of $45 million, and while losses in the Cayman insurance segment widened, management is confident that efforts on underwriting performance will yield positive results in the upcoming quarters.

  5. Capital Expenditure: Management projected a significant capital expenditure of approximately INR 3,000 crore, funded by internal accruals and debt, to support growth objectives.

  6. Market Presence: Future expansion efforts will prioritize core markets, particularly in Bangalore and Kolkata, to consolidate their market presence and drive further revenue growth.

Overall, the management is focused on sustaining double-digit revenue growth in India, optimizing insurance offerings, and improving operational efficiencies across international markets, indicating a strategy aimed at long-term growth and profitability.

Major Q&A from the Earnings Call:

  1. Question: "Do we expect the same trend of high profit growth in the India business to continue for a few more quarters? Are there still levers for margin expansion?" Answer: "We've implemented transformation programs and payor mix optimization initiatives over the last few years, yielding higher patient volumes and revenues. Although we don't have specific guidance, we aim to maintain our margins, barring unforeseen impacts."

  2. Question: "When should we expect breakeven for the insurance and clinics segment?" Answer: "Currently, we're focused on building this segment and attracting customers. Breakeven timing is too early to disclose, but we aim to minimize losses and will update investors on our spending trajectory."

  3. Question: "What distinguishes the average revenue per patient in Bangalore compared to other clusters?" Answer: "Bangalore's higher ARPP is largely due to advanced procedures like robotic surgery and transplants. While we aim to replicate this in other regions, we expect a structural difference due to varying case mixes and payor profiles."

  4. Question: "What are the plans for the UK operations to improve profitability?" Answer: "The UK market is different, but we're focusing on applying technology and operational efficiencies from our Cayman experience. While margins may not reach Indian levels, we're targeting increased market share from private insurers, which will help."

  5. Question: "Can we expect any timeline for cost efficiencies in the UK's doctor and employee expenses?" Answer: "We anticipate gradual improvements over the medium term as we enhance our efficiency through new technologies and processes. Focused changes will help reduce costs as a percentage of revenue."

  6. Question: "What is your vision for NH in the next five years?" Answer: "We aim to establish a significant presence in core markets so that every community is within 25 minutes of an NH facility. We aspire to be a trusted provider while expanding our offerings across clinics, hospitals, and insurers."

  7. Question: "What is the current status of debt and its repayment?" Answer: "We have a GBP 150 million debt with a 2+5 repayment structure. Initially, we service interest only, then commence equal principal and interest repayments over the following five years."

  8. Question: "Are you planning to further expand your international presence?" Answer: "Currently, our focus remains on optimizing UK operations and enhancing our performance in Cayman. No immediate plans for new international acquisitions are in place."

Revenue Breakdown

Analysis of Narayana Hrudayalaya's financial performance, highlighting revenue trends, growth patterns, and key metrics through quarterly analysis.

Last Updated: Dec 31, 2025

DescriptionShareValue
Medical and healthcare related services93.5%2.1 kCr
Others5.5%121.6 Cr
Add: Unallocated other income1.1%23.3 Cr
Total2.2 kCr

Share Holdings

Understand Narayana Hrudayalaya ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.

Holding Pattern

Share Holding Details

Shareholder NameHolding %
SHAKUNTALA SHETTY34.8%
DEVI PRASAD SHETTY11.66%
VIREN PRASAD SHETTY5%
VARUN SHETTY5%
ANESH SHETTY5%
KIRAN MAZUMDAR SHAW2.3%
MIRAE ASSET NIFTY SMALLCAP 250 MOMENTUM QUALITY 102.2%
NARAYANA HEALTH ACADEMY PVT LTD1.81%
FRANKLIN TEMPLETON INVESTMENT FUNDS - FRANKLIN IND1.27%
RENUKA JAGTIANI1.08%
AMEYA SHETTY0%

Overall Distribution

Distribution across major stakeholders

Ownership Distribution

Distribution across major institutional holders

Is Narayana Hrudayalaya Better than it's peers?

Detailed comparison of Narayana Hrudayalaya against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.

Ticker
Name
Mkt Cap
Revenue
Price %, 1M
Returns, 1Y
P/E
P/S
Rev 1-Yr
Inc 1-Yr
APOLLOHOSPApollo Hospitals Enterprises1.06 LCr24.42 kCr-4.40%+10.00%58.924.35--
MAXHEALTHMax Healthcare Institute90.76 kCr8.3 kCr-10.50%-18.00%63.910.93--
FORTISFortis Healthcare60.84 kCr8.84 kCr-9.70%+24.10%63.366.89--
MEDANTAGlobal Health27.74 kCr4.27 kCr-7.00%-16.40%53.986.5--
KRISHANAKrishana Phoschem3.42 kCr2.15 kCr+13.80%+136.80%26.371.59--

Sector Comparison: NH vs Healthcare Services

Comprehensive comparison against sector averages

Comparative Metrics

NH metrics compared to Healthcare

CategoryNHHealthcare
PE43.7257.43
PS4.985.84
Growth25.5 %12.9 %
0% metrics above sector average
Key Insights
  • 1. NH is among the Top 5 Hospital companies by market cap.
  • 2. The company holds a market share of 9.3% in Hospital.
  • 3. In last one year, the company has had an above average growth that other Hospital companies.

Income Statement for Narayana Hrudayalaya

Consolidated figures (in Rs. Crores) /
Description(%) Q/QMar-2025Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020
Revenue From Operations9.3%5,4835,0184,5253,7012,5823,128
Other Income23%927565352824
Total Income9.5%5,5755,0934,5903,7362,6113,152
Purchases of stock-in-trade2.6%1,1411,1121,012921665722
Employee Expense8.9%1,0931,004879768627674
Finance costs51%1469769667685
Depreciation and Amortization14.9%278242210183184186
Other expenses10.6%1,9771,7881,6791,3701,0951,286
Total Expenses10.1%4,6314,2053,8383,2982,6602,976
Profit Before exceptional items and Tax6.2%944889752438-49.23176
Exceptional items before tax--8.360-0.19-8.53-6.84-10.87
Total profit before tax5.3%936889752430-56.07165
Current tax-5.8%130138140500.3541
Deferred tax137.8%16-38.74.5338-42.121.22
Total tax48%1469914588-41.7742
Total profit (loss) for period0.1%791790607342-14.29119
Other comp. income net of taxes153.8%34145726-2.024.66
Total Comprehensive Income2.6%824803663368-16.31124
Earnings Per Share, Basic0.1%38.938.8629.8516.85-0.75.86
Earnings Per Share, Diluted0.1%38.938.8629.8516.84-0.75.86
Debt equity ratio0.1%067056000-
Debt service coverage ratio-0.7%0.02510.032000-
Interest service coverage ratio-3.1%0.07390.1017000-
Description(%) Q/QDec-2025Sep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Revenue From Operations30.9%2,1511,6441,5071,4751,3671,400
Other Income-4.3%232424271824
Total Income30.4%2,1741,6681,5311,5021,3851,424
Purchases of stock-in-trade26.1%407323305305270317
Employee Expense53.7%459299296275277282
Finance costs56.1%654245413735
Depreciation and Amortization40.7%1228784827065
Other expenses52.2%943620569537506509
Total Expenses43.8%1,9711,3711,3001,2411,1661,192
Profit Before exceptional items and Tax-31.8%203297231261219232
Exceptional items before tax--50.9400-8.3600
Total profit before tax-49%152297231253219232
Current tax-17.1%303634422929
Deferred tax-22000%-7.840.960.6215-3.083.88
Total tax-41.7%223735572633
Total profit (loss) for period-51%127258197197193199
Other comp. income net of taxes-57.4%30690.46-5.86365.34
Total Comprehensive Income-52.3%157328197191229204
Earnings Per Share, Basic-55.3%6.2412.729.689.719.59.78
Earnings Per Share, Diluted-55.3%6.2412.729.689.719.59.78
Debt equity ratio0.7%0.0130580580670550.01
Debt service coverage ratio-1.3%0.01930.03160.02410.02570.02810.03
Interest service coverage ratio-5.1%0.03310.07990.06110.07220.06980.08
Standalone figures (in Rs. Crores) /
Description(%) Q/QMar-2025Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020
Revenue From Operations9.9%3,5903,2662,9612,4121,6542,239
Other Income15.6%1421231051067624
Total Income10.1%3,7323,3893,0662,5181,7302,263
Purchases of stock-in-trade4.8%828790715661467540
Employee Expense10.3%688624566504403449
Finance costs64.2%885445394349
Depreciation and Amortization5%169161139119123128
Other expenses8.7%1,3911,2801,210996804978
Total Expenses10.1%3,1762,8862,6722,3131,8512,159
Profit Before exceptional items and Tax10.8%557503395206-120.99104
Exceptional items before tax-000000
Total profit before tax10.8%557503395206-120.99104
Current tax-10.2%10711912036037
Deferred tax143.8%19-40.149.1536-42.31-1.09
Total tax60.3%1267912972-42.3136
Total profit (loss) for period1.4%431425266134-78.6768
Other comp. income net of taxes-63.7%-4.42-2.31-1.81.571.8-4.6
Total Comprehensive Income1.2%427422264135-76.8763
Earnings Per Share, Basic1.7%21.2320.913.086.58-3.883.34
Earnings Per Share, Diluted1.7%21.2320.913.086.58-3.883.34
Debt equity ratio0.2%073055000-
Debt service coverage ratio-0.1%0.02790.0289000-
Interest service coverage ratio-3.3%0.07350.1029000-
Description(%) Q/QDec-2025Sep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Revenue From Operations-4.9%9691,019943919865934
Other Income-6.2%1617161078.6513
Total Income-4.9%9851,0369601,026874947
Purchases of stock-in-trade-7.7%218236221221190214
Employee Expense-3.4%174180176166169178
Finance costs0%292931262120
Depreciation and Amortization2.2%474648464342
Other expenses-0.3%372373364355347359
Total Expenses-2.9%840865842815772814
Profit Before exceptional items and Tax-15.3%145171117211101134
Exceptional items before tax--45.2800000
Total profit before tax-42.4%99171117211101134
Current tax-16.1%273229382323
Deferred tax-658.3%-3.691.841.2413-0.65.45
Total tax-28.1%243330512228
Total profit (loss) for period-45.3%761388716079106
Other comp. income net of taxes-269.7%-1.440.34-0.44-1.32-0.23-0.39
Total Comprehensive Income-46.7%741388715979105
Earnings Per Share, Basic-52.8%3.736.794.37.883.95.2
Earnings Per Share, Diluted-52.8%3.736.794.37.883.95.2
Debt equity ratio0%0730690650730540
Debt service coverage ratio-1%0.02430.03350.02250.03680.02060.03
Interest service coverage ratio-2.8%0.04410.06990.04830.09250.05770.08

Balance Sheet for Narayana Hrudayalaya

Consolidated figures (in Rs. Crores) /
Description(%) Q/QSep-2025Mar-2025Sep-2024Mar-2024Sep-2023Mar-2023
Cash and cash equivalents-9.4%414457246264112155
Current investments33.3%1,306980857840524251
Loans, current-000000
Total current financial assets9%2,5152,3081,8071,7681,5111,150
Inventories0.9%1111101201107572
Total current assets11.7%2,7942,5022,0471,9461,6761,294
Property, plant and equipment3.5%3,9473,8142,6162,1982,0751,923
Capital work-in-progress94.2%13570737514365259
Goodwill0.8%120119118118118117
Non-current investments11.7%116104544.471.590.51
Loans, non-current3.4%939088868482
Total non-current financial assets7.3%266248199147142139
Total non-current assets4.9%4,9484,7154,1963,6793,1112,868
Total assets6.6%7,7427,2656,2435,6254,7874,162
Borrowings, non-current-1.8%1,9311,9661,2681,195811626
Total non-current financial liabilities-3.2%2,1182,1881,4801,408965792
Provisions, non-current10.6%534849414035
Total non-current liabilities-2.7%2,3782,4441,7111,6291,2021,042
Borrowings, current-17.1%205247245249150136
Total current financial liabilities8.9%1,0199361,084923852828
Provisions, current10.3%655960505148
Current tax liabilities-11.1%252862241.844.59
Total current liabilities8.8%1,2471,1461,3241,1101,082987
Total liabilities1.2%3,6803,6373,0362,7392,2842,030
Equity share capital0%204204204204204204
Non controlling interest20.5%2.061.881.691.411.241.05
Total equity12%4,0623,6283,2072,8852,5032,132
Total equity and liabilities6.6%7,7427,2656,2435,6254,7874,162
Standalone figures (in Rs. Crores) /
Description(%) Q/QSep-2025Mar-2025Sep-2024Mar-2024Sep-2023Mar-2023
Cash and cash equivalents-55.9%1102481381017970
Current investments99%60030215223111339
Loans, current163.6%301246111417
Total current financial assets9.3%1,1131,018666696596479
Inventories-9.3%404447553832
Total current assets9.5%1,1761,074758778666538
Property, plant and equipment1.6%2,1032,0691,6531,2221,0971,078
Capital work-in-progress261.5%952737345232
Goodwill0%222222222222
Non-current investments0.8%871864789790637639
Loans, non-current3.4%939088868482
Total non-current financial assets1.3%1,0221,009935933778779
Total non-current assets3%3,5273,4252,9512,7152,2602,237
Total assets4.5%4,7034,4993,7103,4932,9262,775
Borrowings, non-current3.5%1,3891,342721794460459
Total non-current financial liabilities3.2%1,5041,458828884543549
Provisions, non-current11.6%494444383531
Total non-current liabilities3.2%1,6481,597940986658678
Borrowings, current-33.1%9013413112810384
Total current financial liabilities2.2%596583661548566526
Provisions, current11.1%514647384137
Current tax liabilities-4%25265120--
Total current liabilities2.5%735717822666664628
Total liabilities3%2,3832,3141,7621,6531,3221,306
Equity share capital0%204204204204204204
Total equity6.1%2,3192,1861,9481,8401,6041,469
Total equity and liabilities4.5%4,7034,4993,7103,4932,9262,775

Cash Flow for Narayana Hrudayalaya

Consolidated figures (in Rs. Crores) /
Description(%) Q/QMar-2025Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020
Finance costs51%146976966--
Change in inventories96.7%-0.31-38.38-11.7-11.54--
Depreciation14.9%278242210183--
Unrealised forex losses/gains10%12113911--
Adjustments for interest income25%2117102.04--
Share-based payments-0000.26--
Net Cashflows from Operations-3.6%1,1161,1581,170552--
Income taxes paid (refund)38.9%126918667--
Net Cashflows From Operating Activities-7.2%9901,0671,085485--
Cashflows used in obtaining control of subsidiaries-002430--
Proceeds from sales of PPE-4.3%33.090.940.49--
Purchase of property, plant and equipment10.6%1,074971522251--
Interest received-11.8%16187.611.28--
Other inflows (outflows) of cash48.2%-262.76-508.51-337.32-20.65--
Net Cashflows From Investing Activities9.7%-1,317.12-1,457.94-1,174.1-266.91--
Proceeds from exercise of stock options-3.1%00.030.110.02--
Proceeds from issuing debt66.9%50030000--
Proceeds from borrowings-3.4%50552327767--
Repayments of borrowings44.2%22315568135--
Payments of lease liabilities-5.5%53565755--
Dividends paid60%8151200--
Interest paid59.7%116734336--
Net Cashflows from Financing Activities9%53248888-158.95--
Effect of exchange rate on cash eq.63.5%0.650.04-2.13-0.13--
Net change in cash and cash eq.112.5%20597-3.9359--
Standalone figures (in Rs. Crores) /
Description(%) Q/QMar-2025Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020
Finance costs64.2%88544539--
Change in inventories145.3%12-23.28-2.86-6.04--
Depreciation5%169161139119--
Impairment loss / reversal-0.57000--
Unrealised forex losses/gains96.4%0.980.444.93.35--
Dividend income8%82765176--
Adjustments for interest income12.5%1917125.22--
Share-based payments-0000.26--
Net Cashflows from Operations1.8%625614593301--
Income taxes paid (refund)42.3%102727755--
Net Cashflows From Operating Activities-3.5%523542516246--
Cashflows used in obtaining control of subsidiaries-101%01002000--
Proceeds from sales of PPE-85.2%1.313.090.450.38--
Purchase of property, plant and equipment39.7%705505245181--
Proceeds from sales of investment property-005.760--
Proceeds from sales of long-term assets-001890--
Purchase of other long-term assets-002120--
Cash receipts from repayment of advances and loans made to other parties168%68265.50--
Dividends received8%82765176--
Interest received-34.3%9.54146.020.29--
Other inflows (outflows) of cash63.6%-66.57-184.58-129.56-12.4--
Net Cashflows From Investing Activities0.8%-754.2-760.64-621.22-117.04--
Proceeds from exercise of stock options-3.1%00.030.110--
Proceeds from issuing debt66.9%50030000--
Proceeds from borrowings10.5%19017223064--
Repayments of borrowings15.1%1231077761--
Payments of lease liabilities-35.5%21323737--
Dividends paid60%8151200--
Interest paid65.9%74453123--
Other inflows (outflows) of cash-0000.02--
Net Cashflows from Financing Activities65.3%39123765-56.61--
Effect of exchange rate on cash eq.--0.65000--
Net change in cash and cash eq.777.8%15919-40.272--

What does Narayana Hrudayalaya Limited do?

Hospital•Healthcare•Mid Cap

Narayana Hrudayalaya Limited engages in the medical and healthcare services in India and internationally. It operates through two segments, Medical and Healthcare Related Services; and Others. The company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centres, nursing homes and other related activities. It offers cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology services. The company engages in health insurance business. The company was incorporated in 2000 and is headquartered in Bengaluru, India.

Industry Group:Healthcare Services
Employees:11,659
Website:www.narayanahealth.org

Important Disclosure & Data Context

This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.

Performance Comparison

NH vs Healthcare (2021 - 2026)

NH is underperforming relative to the broader Healthcare sector and has declined by 48.7% compared to the previous year.